Evaluation Guidelines for the Clinical and Translational Science Awards (CTSAs)
Evaluation Guidelines for the Clinical and Translational Science Awards (CTSAs)
复制标题
DOI：
10.1111/cts.12036
复制
发表时间：
2013-08-01
影响因子：
3.9
通讯作者：
Thomas, Veronica G.
中科院分区：
文献类型：
--
作者：
Trochim, William M.;Rubio, Doris M.;Thomas, Veronica G.
美国国立卫生研究院下属的国家转化科学促进中心（NCATS）目前为临床和转化科学奖（CTSA）提供资金，CTSA是由30个州和哥伦比亚特区的61个医学研究机构组成的国家联盟。该计划旨在改变生物医学研究的方式，加快实验室发现转化为患者治疗方法，让社区参与临床研究工作，并培养新一代临床和转化研究人员。像CTSA计划这样雄心勃勃和复杂的奋进需要高质量的评估，以表明该计划得到了良好的实施，有效的管理和明显的有效性。本文介绍了CTSA联盟评估关键职能委员会评估CTSA项目的总体框架，并提出了指导评估工作的政策。所提出的准则旨在作为一个工具，在CTSA社区内的教育，阐明关键问题和做法，应考虑在评价规划，实施和利用。此外，这些准则可以为目前关于如何最有效地将本文件所阐述的原则转化为实际行动的讨论提供基础。
The National Center for Advancing Translational Sciences (NCATS), a part of the National Institutes of Health, currently funds the Clinical and Translational Science Awards (CTSAs), a national consortium of 61 medical research institutions in 30 states and the District of Columbia. The program seeks to transform the way biomedical research is conducted, speed the translation of laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train a new generation of clinical and translational researchers. An endeavor as ambitious and complex as the CTSA program requires high-quality evaluations in order to show that the program is well implemented, efficiently managed, and demonstrably effective. In this paper, the Evaluation Key Function Committee of the CTSA Consortium presents an overall framework for evaluating the CTSA program and offers policies to guide the evaluation work. The guidelines set forth are designed to serve as a tool for education within the CTSA community by illuminating key issues and practices that should be considered during evaluation planning, implementation, and utilization. Additionally, these guidelines can provide a basis for ongoing discussions about how the principles articulated in this paper can most effectively be translated into operational reality.